VALENTIS, INC.

ALPHASWITCH

Pharmaceutical preparations for use in gene therapy, namely, nucleic acids for regulated expression of therapeutics.;ALPHA SWITCH;

BETASWITCH

Pharmaceutical preparations for use in gene therapy, namely nucleic acids for regulated expression of therapeutics;BETA SWITCH;

CLIC

CLICK;medical and scientific research in the field of synthetic gene delivery systems; development and testing of products for gene delivery; licensing of intellectual property rights in the field of gene delivery; provision of technical know-how, namely consultation and technical advice in the field of condensing formulations for gene delivery;

CLIPID

pharmaceutical preparations for use in gene therapy, namely, lipid preparations for delivery of nucleic acids to cells;

CONVERTING GENOMIC DISCOVERIES INTO MEDICINES

SCIENTIFIC RESEARCH AND DEVELOPMENT OF PHARMACEUTICAL, BIOLOGICAL AND BIOTECHNICAL PRODUCTS;

DELTA-CAD

DELTA CARDIOVASCULAR ANGIOGENESIS DISEASE;medical and scientific research in the field of cardiovascular disease; development and testing of products for therapeutic angiogenesis; research and develoment of new products for others in the field of therapeutic angiogenesis;

DELTA-PAD

DELTA PAD;medical and scientific research in the field of cardiovascular disease; development and testing of products for therapeutic angiogenesis; research and develoment of new products for others in the field of therapeutic angiogenesis;

DELTAVASC

Preparations for clinical or medical laboratory use; pharmaceutical preparations for treatment of ischemia; cardiovascular treatment preparations;DELTA VASCULAR;Pharmaceutical drug development services; medical and scientific research in the field of gene therapy; development and testing of products for gene therapy and therapeutic angiogenesis; licensing of intellectual property in the fields of gene therapy and therapeutic angiogenesis.;

DNAVAX

medical and scientific research in the field of synthetic gene delivery systems; development and testing of products for gene delivery; licensing of intellectual property rights in the field of gene delivery; provision of technical know-how, namely consultation and technical advice in the field of formulations for gene delivery;

EPOSWITCH

Pharmaceutical preparations for the treatment of anemia;

EPOSWITCH

Pharmaceutical preparations for the treatment of anemia;

GENEMEDICINE

GENE MEDICINE;scientific research and development of drugs to treat disease;

GENEMEDICINE, INC.

formulated nucleic acid pharmaceutical preparations for the treatment of disease;

HERMES

medical and scientific research in the field of gene expression systems; development and testing of systems for gene expression; licensing of intellectual property rights in the field of gene expression; provision of technical know-how, namely consultation and technical advice, in the field of expression systems for gene therapy;

IFN SWITCH

Pharmaceutical preparations for use in gene therapy, namely nucleic acids for regulated expression of therapeutics.;

IFN SWITCH

Pharmaceutical preparations for use in gene therapy, namely nucleic acids for regulated expression of therapeutics;

MULTIVAX

gene-based pharmaceutical preparations used to elicit an immune response to selected antigens for the treatment or prevention of infectious disease or cancer;

PINC

polymer delivery system sold as integral component of pharmaceuticals for human, livestock and domestic pet use, namely, for non-viral gene delivery;PINK;polymer delivery chemicals for use in the manufacture of human and animal pharmaceuticals, including nucleic acids;

PINC

medical and scientific research in the field of synthetic gene delivery systems; development and testing of products for gene delivery; licensing of intellectual property rights in the field of gene delivery; provision of technical know-how, namely consultation and technical advice in the field of formulations for gene delivery;

VALENTIS

pharmaceuticals, namely, formulated nucleic acid pharmaceutical preparations for the treatment of cancer, neuromuscular disorders, cardiovascular diseases, rheumatolgical diseases, and pulmonary diseases;

VALENTIS

technical consultation and research and development of new products for others in the fields of pharmaceutical, biological and biotechnological products;